Resource Type
Technology / DeviceEquipmentTechnology
Resource Name

CRISPR-Cas9 conjugation platform for engineering designer beta cells

Canonical Identifier
US2020/026264
Description
This technology relies on newly described chemical modifications that allow site-specific and multiple-site conjugation of a wide assortment of molecules on both the termini and internal sites of Cas9, creating a platform for endowing Cas9 with diverse functions. Using this platform, Cas9 can be modified to more precisely incorporate exogenously supplied single-stranded oligonucleotide donor (ssODN) at the DNA break site. We demonstrate that the multiple-site conjugation of ssODN to Cas9 significantly increases the efficiency of precision genome editing, and such a platform is compatible with ssODNs of diverse lengths.
Contributors
NameOrganizationConsortiumContact
Bridget WagnerBroad InstituteCTAR Contact
Jeff KarpCHIB Contact
Amit ChoudharyBroad InstituteCTAR Contact
Tags or Keywords
Defining Manuscript Identifier


Have you used this resource?




.